Table 3.

Incidence of hypocalcemia.

A.	Median	Minimum	Q1	Q3	Maximum	IQR	No. of cases	No. of patients
Transient hypocalcemia in %
BABA-ET (16, 33, 34, 36, 53, 54, 65, 66, 69, 80, 85, 103, 109)	14.0	0.0	3.3	28.2	46.2	24.9	259	1,208
BABA-RT (21, 22, 29–32, 51, 63, 66, 68, 69, 74, 79, 90, 109)	21.6	2.8	10.8	31.7	38.6	20.9	283	1,171
MIVAT (26, 38, 39, 42, 44, 46, 47, 52, 62, 71, 73, 87, 98, 99, 110)	5.6	0.0	3.0	10.0	23.4	7.0	231	3,588
TOETVA (14, 18, 19, 43, 91, 93, 102, 106, 107)	7.1	0.0	4.0	21.3	50.0	17.3	64	644
RA-ET (25, 27, 35, 92)	0.0	0.0	0.0	2.8	5.8	2.8	1	84
RA-RT (101)	33.3	NA	NA	NA	NA	NA	1	3
GTET (28, 40, 41, 55, 59, 64, 73, 76, 84)	3.3	0.0	0.0	26.7	33.3	26.7	95	1,020
RATS (15, 24, 28, 37, 45, 48, 49, 56, 57, 59, 60, 67, 70, 75, 76, 78, 81–84, 89, 94, 95, 97, 100, 108)	18.4	0.0	8.3	39.9	51.7	31.7	2,239	7,002
Standard of care (14–16, 22, 31, 32, 36, 45, 48, 51, 52, 54, 55, 64, 68, 81, 82, 89, 90, 93, 103, 107, 110)	17.1	0.0	4.5	34.0	44.6	29.5	631	3,157
B.	Median	Minimum	Q1	Q3	Maximum	IQR	No. of cases	No. of patients
Permanent hypocalcemia in %
BABA-ET (16, 34, 36, 54, 65, 66, 69, 80, 85, 103, 109)	1.3	0.0	0.0	2.1	4.2	2.1	25	1,048
BABA-RT (21, 22, 29–32, 51, 63, 66, 68, 69, 74, 79, 90, 109)	0.9	0.0	0.0	1.7	4.8	1.7	13	1,171
MIVAT (26, 38, 39, 46, 52, 62, 71, 73, 87, 88, 98, 99, 105, 110)	0.0	0.0	0.0	0.0	0.4	0.4	23	3,402
TOETVA (14, 18, 19, 43, 91, 93, 102, 106, 107)	0.0	0.0	0.0	0.7	5.0	0.7	2	644
RA-ET (25, 27, 35, 92)	0.0	0.0	0.0	0.0	0.0	0.0	0	84
RA-RT (101)	0.0	NA	NA	NA	NA	NA	0	3
GTET (28, 40, 41, 55, 59, 64, 73, 76, 84)	0.0	0.0	0.0	0.7	2.7	0.7	4	1,020
RATS (24, 28, 37, 45, 48, 49, 56, 57, 59, 60, 67, 70, 75, 76, 78, 81–84, 89, 94, 95, 97, 100, 108)	0.0	0.0	0.0	0.1	3.1	0.1	45	6,986
Standard of care (14, 16, 22, 31, 32, 36, 45, 48, 51, 52, 54, 55, 64, 68, 88–90, 93, 103, 105, 108, 110)	1.5	0.0	0.0	3.2	6.7	3.2	57	3,024

Q1, first quartile; Q3, third quartile; IQR, interquartile range; NA, not applicable.